This document is a publication of a European patent application (EP2024044334A2) filed by Ranok Therapeutics (Hangzhou) Co. Ltd. The application pertains to "METHODS AND COMPOSITIONS FOR MODULATING KRAS(G12D)" and was published on March 18, 2026. The application includes IPC classifications related to organic chemistry, pharmaceutical preparations, and treatments for cancer.

As this is a patent application publication, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in cancer therapeutics and may be of interest to pharmaceutical companies and drug manufacturers for competitive intelligence and R&D monitoring. The designated states indicate broad European coverage for potential patent protection.